Internal Medicine, Infectious Disease · West Columbia, SC
NPI
1164663068
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
146 E Hospital Dr Ste 120a
West Columbia, SC, 29169
Phone (803) 936-7460
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,017 services
Medicare patients, 2024
234
Average age 74
Drug cost, 2024
$649K
716 prescriptions
Company payments, 2025
$448
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth B Nimmich was code 99232 (hospital e&m - subsequent), 345 times for 133 patients. In total Elizabeth B Nimmich billed 1,017 services in 24 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 345 | 133 | $59.14 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 208 | 94 | $88.14 | $18K |
| 99223 Hospital E&M - Initial | Facility | 153 | 134 | $128.47 | $20K |
| 99214 Office E&M - Established | Office | 123 | 61 | $90.49 | $11K |
| 99222 Hospital E&M - Initial | Facility | 50 | 47 | $98.26 | $4,913 |
| 99213 Office E&M - Established | Office | 32 | 28 | $64.56 | $2,066 |
| 36415 Venipuncture Blood Collection | Office | 22 | 18 | $8.18 | $180 |
| 99231 Hospital E&M - Subsequent | Facility | 20 | 13 | $37.27 | $745 |
By year: 2022 $85K for 1,289 services; 2023 $94K for 1,008 services; 2024 $81K for 1,017 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 22 | 18 | $8.18 | $180 |
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth B Nimmich prescribed most often to Medicare patients was Cephalexin, with 62 prescriptions and refills. In total Elizabeth B Nimmich wrote 716 Medicare prescriptions that cost $649K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 62 | 66 | 13 | $744 |
| Doxycycline Hyclate Generic | 54 | 71 | 20 | $1,446 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 50 | 50 | Under 11 | $194K |
| Daptomycin Generic | 48 | 48 | Under 11 | $51K |
| Cefepime Hcl Generic | 33 | 33 | Under 11 | $8,615 |
| Ciprofloxacin Hcl Generic | 29 | 40 | Under 11 | $292 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 29 | 29 | Under 11 | $110K |
| Azithromycin Generic | 27 | 39 | Under 11 | $571 |
| Amoxicillin Generic | 27 | 36 | Under 11 | $149 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 23 | 23 | Under 11 | $637 |
| Tigecycline Generic | 22 | 22 | Under 11 | $12K |
| Rifampin Generic | 20 | 32 | Under 11 | $1,101 |
| Fluconazole Generic | 19 | 19 | 11 | $233 |
| Amikacin Sulfate Generic | 18 | 18 | Under 11 | $1,668 |
| Ertapenem Ertapenem Sodium | 17 | 17 | Under 11 | $3,693 |
Brand drugs: 146 claims; generic drugs: 570 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth B Nimmich $448 ($448 in general payments such as food, travel and fees) from 12 companies. The largest payer was Gilead Sciences, Inc. with $131.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 5 | $131 |
| ViiV Healthcare Company GSK | 3 | $63.89 |
| Merck Sharp & Dohme LLC MRK | 3 | $54.51 |
| Theratechnologies Inc. THTX | 1 | $33.54 |
| La Jolla Pharmaceutical Company | 1 | $25.45 |
| Aimmune Therapeutics, Inc. | 1 | $23.32 |
| Melinta Therapeutics, LLC | 1 | $23.09 |
| Astellas Pharma US Inc 4503.T | 1 | $22.05 |
| Insmed, Inc. INSM | 1 | $21.86 |
| Ferring Pharmaceuticals Inc. | 1 | $17.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.